Dr. Martens (LON:DOCS) Trading Up 25.8% – Should You Buy?

Dr. Martens plc (LON:DOCS)’s share price was up 25.8% during mid-day trading on Thursday . The company traded as high as GBX 76 ($1.03) and last traded at GBX 75.40 ($1.02). Approximately 8,360,099 shares were traded during trading, an increase of 271% from the average daily volume of 2,253,727 shares. The stock had previously closed at GBX 59.95 ($0.81).

Wall Street Analysts Forecast Growth

Separately, Royal Bank of Canada lowered their target price on shares of Dr. Martens from GBX 7,000 ($94.70) to GBX 6,000 ($81.17) and set a “sector perform” rating on the stock in a research report on Monday, May 19th.

Dr. Martens Stock Performance

The stock’s fifty day moving average is GBX 55.34 and its two-hundred day moving average is GBX 62.80. The firm has a market capitalization of £795.54 million, a price-to-earnings ratio of 11.62, a price-to-earnings-growth ratio of 6.40 and a beta of 0.11. The company has a debt-to-equity ratio of 127.27, a quick ratio of 1.13 and a current ratio of 2.85.

Dr. Martens (LON:DOCS) last announced its quarterly earnings data on Thursday, June 5th. The company reported GBX 2.40 ($0.03) earnings per share for the quarter. Dr. Martens had a net margin of 7.89% and a return on equity of 18.91%. Analysts forecast that Dr. Martens plc will post 2.5809394 earnings per share for the current year.

Dr. Martens Cuts Dividend

The business also recently declared a dividend, which was paid on Tuesday, April 8th. Shareholders of record on Thursday, March 6th were given a dividend of GBX 0.85 ($0.01) per share. The ex-dividend date of this dividend was Thursday, March 6th. This represents a dividend yield of 1.47%. Dr. Martens’s dividend payout ratio (DPR) is 42.53%.

Insider Transactions at Dr. Martens

In other news, insider Giles Wilson bought 32,640 shares of the company’s stock in a transaction dated Tuesday, March 25th. The shares were acquired at an average cost of GBX 54 ($0.73) per share, with a total value of £17,625.60 ($23,844.16). Insiders have acquired 33,206 shares of company stock valued at $1,792,771 in the last quarter. Insiders own 4.36% of the company’s stock.

About Dr. Martens

Dr. Martens is an iconic British brand founded in 1960 in Northamptonshire. Originally produced for workers looking
for tough, durable boots, the brand was quickly adopted by diverse youth subcultures and associated musical
movements. Dr. Martens have since transcended their working-class roots while still celebrating their proud heritage
and, six decades later, “Docs” or “DMs” are worn by people around the world who use them as a symbol of
empowerment and their own individual attitude.

The Company successfully listed on the main market of the London Stock Exchange on 29 January 2021 (DOCS.L) and
is a constituent of the FTSE 250 index.